Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 149 medicines, including monocomponent insulins, dettol antiseptic and aspirin with combinations. The brands concerned are from companies such as Eli Lilly, Shreya Life Sciences, Reckitt Benckiser, Aventis Pharma, Wockhardt and Pfizer Products.

The NPPA has revised both ceiling and non-ceiling prices of medicines. It is learnt that prices in case of 14 formulation packs have been reduced by the pricing authority. The pricing authority has reduced the prices of seven monocomponent insulins. While four of these brands are from Eli Lilly, prices of three monocomponent insulins from Shreya Life Sciences have also been reduced.

The price revision in case of monocomponents is in the range of 0.10 – 9.90%. For instance, a 10-ml vial pack of Eli Lilly’s monocomponent insulin would now cost Rs 158 instead of Rs 163.65, whereas a 3-ml cartridge of Recosulin M30 from Shreya Life Sciences would now cost Rs 197.23 instead of Rs 203.11.

NPPA has also reduced the price of Reckitt Benckiser’s dettol antiseptic liquid (50-ml pack) to Rs 110.30 from Rs 110.94. However, in addition to this the pricing authority has also fixed the ceiling prices of dettol’s nine different packs. NPPA has also directed the manufacturing company to approach it again for price fixation in case of any change in the packing material used or any special feature claimed.

Besides, the drug price regulator has allowed increase in prices of several medicines. For instance, the price of Pfizer’s Depo-Medrol tablets and injections have been revised in the range of 4.21-5.73%.  These prices have been fixed in accordance with the provisions of the Drugs Prices Control Order (DPCO), 1995. According to guidelines of the pricing authority, the prices fixed by it have to be mandatorily implemented by the manufacturing and marketing companies of these medicines.

Three formulation packs from Aventis became costlier to the consumers. Aspirin, vitamin E, prednisolone, dexamethasone, levosaltbutamol, rifampicin, doxycycline, salbutamol, metronidazole, gentamycin and betamethasone combination packs were also among those whose prices have been increased by the NPPA through the notification dated October 1.